LifeVantage Corporation

Equities

LFVN

US53222K2050

Pharmaceuticals

Market Closed - Nasdaq 04:30:01 2024-04-26 pm EDT 5-day change 1st Jan Change
6.185 USD -0.88% Intraday chart for LifeVantage Corporation -7.69% +3.08%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
LifeVantage Corporation Enters Loan Agreement with Bank of America, N.A CI
Transcript : LifeVantage Corporation - Special Call
LifeVantage Corporation Announces the Launch of its TrueScience Activated Skin Care Collection CI
Bradley Louis Radoff and Sudbury Capital Management Enter into Cooperation Agreement with LifeVantage Corporation CI
LifeVantage Corporation Appoints Dayton Judd to Its Board of Directors, Audit Committee and the Nominating and Corporate Governance Committee CI
LifeVantage Corporation Announces Expansion of LV360 into Canada, Mexico, and European Markets CI
Lifevantage Keeps Quarterly Cash Dividend at $0.035 a Share, Payable March 15 to Holders of Record March 1 MT
Transcript : LifeVantage Corporation, Q2 2024 Earnings Call, Jan 30, 2024
Earnings Flash (LFVN) LIFEVANTAGE CORPORATION Reports Q2 Revenue $51.6M, vs. Street Est of $54.6M MT
Earnings Flash (LFVN) LIFEVANTAGE CORPORATION Reports Q2 EPS $0.10 MT
LifeVantage Corporation Provides Earnings Guidance for the Fiscal Year 2024 CI
Tranche Update on LifeVantage Corporation's Equity Buyback Plan announced on November 27, 2017. CI
LifeVantage Corporation Declares Quarterly Dividend, Payable on March 15, 2024 CI
LifeVantage Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Key Inflation Data Awaited as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Thursday MT
Lifevantage Says Protandim Nrf2-TrueScience Combination Helps Cells 'Accurately' Respond To Stress Levels MT
LifeVantage Corporation Announces Executive Changes CI
Bradley Louis Radoff and Sudbury Capital Management?s Counsel Delivers a Letter to Counsel to LifeVantage Corporation CI
Declaration of Voting Results by LifeVantage Corporation CI
LifeVantage Corporation Provides Information to Shareholders CI
LifeVantage Corporation Approves Board Appointments CI
Earnings Flash (LFVN) LIFEVANTAGE CORPORATION Reports Q1 EPS $0.13 MT
LifeVantage Corporation Provides Earnings Guidance for the Year 2024 CI
Transcript : LifeVantage Corporation, Q1 2024 Earnings Call, Nov 09, 2023
Earnings Flash (LFVN) LIFEVANTAGE CORPORATION Reports Q1 Revenue $51.4M MT
Chart LifeVantage Corporation
More charts
LifeVantage Corporation is engaged in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. The Company's dietary supplements include its flagship Protandim family of products, LifeVantage Omega+, ProBio, IC Bright, and Daily Wellness dietary supplements. The Protandim product line includes Protandim NRF1 Synergizer, Protandim Nrf2 Synergizer, and Protandim NAD Synergizer. TrueScience is its line of skin, hair, bath and body, and targeted relief products. The Company also markets and sells Petandim, its companion pet supplement formulated to combat oxidative stress in dogs; Axio, its nootropic energy drink mixes, and PhysIQ, its smartweight management system, which includes PhysIQ Fat Burn and PhysIQ Prebiotic, all formulated to aid in weight management.
Calendar
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. LFVN Stock
  4. News LifeVantage Corporation
  5. Lifevantage Says Protandim Nrf2-TrueScience Combination Helps Cells 'Accurately' Respond To Stress Levels